Scientific Literature Search

Source record

Methylphenidate : a treatment for Parkinson's disease?

Devos D, Moreau C, Delval A, Dujardin K, Defebvre L, Bordet R.

CNS Drugs · 2013-01-01

DOI: 10.1007/s40263-012-0017-yPMID: 23160937

A bibliographic record traceable to Europe PMC. Türkçe başlık: makine çevirisi, editoryal kontrol bekliyor.

Article details View source ↗

Open access

Apathy in Parkinson's disease: diagnosis, neuropsychological correlates, pathophysiology and treatment.

Santangelo G, Trojano L, Barone P, Errico D, Grossi D, Vitale C.

Behav Neurol · 2013-01-01

DOI: 10.3233/ben-129025PMID: 23242365

A bibliographic record traceable to Europe PMC. Türkçe başlık: makine çevirisi, editoryal kontrol bekliyor.

Article details View source ↗

Source record

[Rasagiline in monotherapy in patients with early stages of Parkinson's disease and in combined and adjunct therapy to levodopa with moderate and advanced stages].

Pagonabarraga J, Rodríguez-Oroz MC.

Rev Neurol · 2013-01-01

DOI: 10.33588/rn.5601.2012597PMID: 23250679

A bibliographic record traceable to Europe PMC. Türkçe başlık: makine çevirisi, editoryal kontrol bekliyor.

Article details View source ↗

Source record

The many faces of α-synuclein: from structure and toxicity to therapeutic target.

Lashuel HA, Overk CR, Oueslati A, Masliah E.

Nat Rev Neurosci · 2013-01-01

DOI: 10.1038/nrn3406PMID: 23254192

A bibliographic record traceable to Europe PMC. Türkçe başlık: makine çevirisi, editoryal kontrol bekliyor.

Article details View source ↗

Source record

Modeling early Parkinson's disease pathology with chronic low dose MPTP treatment.

Korecka JA, Eggers R, Swaab DF, Bossers K, Verhaagen J.

Restor Neurol Neurosci · 2013-01-01

DOI: 10.3233/rnn-110222PMID: 23271419

A bibliographic record traceable to Europe PMC. Türkçe başlık: makine çevirisi, editoryal kontrol bekliyor.

Article details View source ↗

Source record

Summary of the recommendations of the EFNS/MDS-ES review on therapeutic management of Parkinson's disease.

Ferreira JJ, Katzenschlager R, Bloem BR, Bonuccelli U, Burn D, Deuschl G, Dietrichs E, Fabbrini G, Friedman A, Kanovsky P, Kostic V, Nieuwboer A, Odin P, Poewe W, Rascol O, Sampaio C, Schüpbach M, Tolosa E, Trenkwalder C, Schapira A, Berardelli A, Oertel WH.

Eur J Neurol · 2013-01-01

DOI: 10.1111/j.1468-1331.2012.03866.xPMID: 23279439

A bibliographic record traceable to Europe PMC. Türkçe başlık: makine çevirisi, editoryal kontrol bekliyor.

Article details View source ↗

Source record

Unexpected improvement in levodopa-induced dyskinesia and on-off phenomena after introduction of memantine for treatment of Parkinson's disease dementia.

Vidal EI, Fukushima FB, Valle AP, Villas Boas PJ.

J Am Geriatr Soc · 2013-01-01

DOI: 10.1111/jgs.12058PMID: 23311565

A bibliographic record traceable to Europe PMC. Türkçe başlık: makine çevirisi, editoryal kontrol bekliyor.

Article details View source ↗

Source record

Comments on 'what is a rational antidepressant treatment for major depression in patients with Parkinson's disease?'.

Pae CU.

Psychiatry Clin Neurosci · 2013-01-01

DOI: 10.1111/pcn.12009PMID: 23331292

A bibliographic record traceable to Europe PMC. Türkçe başlık: makine çevirisi, editoryal kontrol bekliyor.

Article details View source ↗

Source record

Therapeutic application of stem cell technology toward the treatment of Parkinson's disease.

Nishimura K, Takahashi J.

Biol Pharm Bull · 2013-01-01

DOI: 10.1248/bpb.b12-00929PMID: 23370347

A bibliographic record traceable to Europe PMC. Türkçe başlık: makine çevirisi, editoryal kontrol bekliyor.

Article details View source ↗

Source record

The genetics of Parkinson's disease: progress and therapeutic implications.

Singleton AB, Farrer MJ, Bonifati V.

Mov Disord · 2013-01-01

DOI: 10.1002/mds.25249PMID: 23389780

A bibliographic record traceable to Europe PMC. Türkçe başlık: makine çevirisi, editoryal kontrol bekliyor.

Article details View source ↗

Source record

Obstacles to the development of a neuroprotective therapy for Parkinson's disease.

Stocchi F, Olanow CW.

Mov Disord · 2013-01-01

DOI: 10.1002/mds.25337PMID: 23390094

A bibliographic record traceable to Europe PMC. Türkçe başlık: makine çevirisi, editoryal kontrol bekliyor.

Article details View source ↗

Source record

Trophic factor gene therapy for Parkinson's disease.

Kordower JH, Bjorklund A.

Mov Disord · 2013-01-01

DOI: 10.1002/mds.25344PMID: 23390096

A bibliographic record traceable to Europe PMC. Türkçe başlık: makine çevirisi, editoryal kontrol bekliyor.

Article details View source ↗

Records come from scientific sources. Bibliographic counts do not represent completed translations or editorial approvals.

22.728 articles found

Methylphenidate : a treatment for Parkinson's disease?

Apathy in Parkinson's disease: diagnosis, neuropsychological correlates, pathophysiology and treatment.

[Rasagiline in monotherapy in patients with early stages of Parkinson's disease and in combined and adjunct therapy to levodopa with moderate and advanced stages].

The many faces of α-synuclein: from structure and toxicity to therapeutic target.

Modeling early Parkinson's disease pathology with chronic low dose MPTP treatment.

Summary of the recommendations of the EFNS/MDS-ES review on therapeutic management of Parkinson's disease.

Unexpected improvement in levodopa-induced dyskinesia and on-off phenomena after introduction of memantine for treatment of Parkinson's disease dementia.

Comments on 'what is a rational antidepressant treatment for major depression in patients with Parkinson's disease?'.

Therapeutic application of stem cell technology toward the treatment of Parkinson's disease.

The genetics of Parkinson's disease: progress and therapeutic implications.

Obstacles to the development of a neuroprotective therapy for Parkinson's disease.

Trophic factor gene therapy for Parkinson's disease.

Filters